Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/12/25 16:50 | 6/10/25 | RYTM | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | 2 | S.d | -158 | 65.34 | 0 | -2 | 3 | D | |||||||||||||||
6/10/25 16:45 | 6/6/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Cramer Pamela J. | MA | O | CHRO | 3 | S.d | -2,185 | 62.74 | 0 | -35 | 19 | D | |||||||||||||||
6/5/25 16:16 | 6/3/25 | RYTM | Health | Drug | Pharmaceutical Preparations | McGirr David W J | MA | D | 1 | S.d | -4,267 | 65.22 | 0 | -65 | 3 | D | ||||||||||||||||
6/5/25 16:16 | 6/3/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Meeker David P | MA | DO | P,CEO | 1 | S.d | -2,837 | 65.05 | 0 | -44 | 202 | D | |||||||||||||||
6/3/25 16:15 | 5/30/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Smith Hunter C | MA | O | CFO | 1 | S.d | -1,437 | 61.41 | 0 | -23 | 110 | D | |||||||||||||||
5/1/25 16:52 | 4/29/25 | RYTM | Health | Drug | Pharmaceutical Preparations | Mazabraud Yann | MA | O | EVP,Head | 3 | S.d | -5,383 | 54.10 | 0 | -99 | 40 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |